Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Fléjou JF, Hansen TP, Hartmann A, Kakar S, Langner C, Nagtegaal I, Puppa G, Riddell R, Ristimäki A, Sheahan K, Smyrk T, Sugihara K, Terris B, Ueno H, Vieth M, Zlobec I, Quirke P. Lugli A, et al. Among authors: quirke p. Mod Pathol. 2017 Sep;30(9):1299-1311. doi: 10.1038/modpathol.2017.46. Epub 2017 May 26. Mod Pathol. 2017. PMID: 28548122 Free article. Review.
Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.
Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Nagtegaal ID, et al. Among authors: quirke p. J Clin Oncol. 2002 Apr 1;20(7):1729-34. doi: 10.1200/JCO.2002.07.010. J Clin Oncol. 2002. PMID: 11919228 Free article. Clinical Trial.
Low rectal cancer: a call for a change of approach in abdominoperineal resection.
Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Nagtegaal ID, et al. Among authors: quirke p. J Clin Oncol. 2005 Dec 20;23(36):9257-64. doi: 10.1200/JCO.2005.02.9231. J Clin Oncol. 2005. PMID: 16361623 Clinical Trial.
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.
van Krieken JH, Jung A, Kirchner T, Carneiro F, Seruca R, Bosman FT, Quirke P, Fléjou JF, Plato Hansen T, de Hertogh G, Jares P, Langner C, Hoefler G, Ligtenberg M, Tiniakos D, Tejpar S, Bevilacqua G, Ensari A. van Krieken JH, et al. Among authors: quirke p. Virchows Arch. 2008 Nov;453(5):417-31. doi: 10.1007/s00428-008-0665-y. Epub 2008 Sep 18. Virchows Arch. 2008. PMID: 18802721 Review.
Revised staging: is it really better, or do we not know?
Nagtegaal ID, Quirke P. Nagtegaal ID, et al. Among authors: quirke p. J Clin Oncol. 2010 Aug 10;28(23):e397-8; author reply e399-400. doi: 10.1200/JCO.2010.28.5726. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20547986 No abstract available.
Evidence-based medicine: the time has come to set standards for staging.
Quirke P, Cuvelier C, Ensari A, Glimelius B, Laurberg S, Ortiz H, Piard F, Punt CJ, Glenthoj A, Pennickx F, Seymour M, Valentini V, Williams G, Nagtegaal ID. Quirke P, et al. J Pathol. 2010 Aug;221(4):357-60. doi: 10.1002/path.2720. J Pathol. 2010. PMID: 20593493
443 results